MedPath

Evaluation of the effect of hyaluronic acid in the prevention of Asherman's syndrome.

Phase 3
Conditions
Asherman syndrome.
Intrauterine synechiae
N85.6
Registration Number
IRCT20200408046993N1
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
80
Inclusion Criteria

Candidates for uterine septal resin surgery who have suffered endometrial damage during surgery.
Age 15-45 years

Exclusion Criteria

BMI > 35 kg/m2
Menopause
Pregnancy
Cervical cancer
Coagulation disorder
Severe pelvic infections
People who do not willing to cooperate after explaining the work.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intrauterine adhesions. Timepoint: Two times, before and 2 months after intervention. Method of measurement: Hysteroscopy and American Society of Reproductive Medicine scoring system.;Volume of menstrual bleeding. Timepoint: Two times, before and 2 months after intervention. Method of measurement: Questionnaire.;Number of menstrual days. Timepoint: Two times, before and 2 months after intervention. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath